257 related articles for article (PubMed ID: 27033685)
1. Complex interplay between brain function and structure during cerebral amyloidosis in APP transgenic mouse strains revealed by multi-parametric MRI comparison.
Grandjean J; Derungs R; Kulic L; Welt T; Henkelman M; Nitsch RM; Rudin M
Neuroimage; 2016 Jul; 134():1-11. PubMed ID: 27033685
[TBL] [Abstract][Full Text] [Related]
2. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P
J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597
[TBL] [Abstract][Full Text] [Related]
3. Increased soluble amyloid-beta causes early aberrant brain network hypersynchronisation in a mature-onset mouse model of amyloidosis.
Ben-Nejma IRH; Keliris AJ; Daans J; Ponsaerts P; Verhoye M; Van der Linden A; Keliris GA
Acta Neuropathol Commun; 2019 Nov; 7(1):180. PubMed ID: 31727182
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI.
Maheswaran S; Barjat H; Rueckert D; Bate ST; Howlett DR; Tilling L; Smart SC; Pohlmann A; Richardson JC; Hartkens T; Hill DL; Upton N; Hajnal JV; James MF
Brain Res; 2009 May; 1270():19-32. PubMed ID: 19272356
[TBL] [Abstract][Full Text] [Related]
5. Early functional connectivity deficits and progressive microstructural alterations in the TgF344-AD rat model of Alzheimer's Disease: A longitudinal MRI study.
Anckaerts C; Blockx I; Summer P; Michael J; Hamaide J; Kreutzer C; Boutin H; Couillard-Després S; Verhoye M; Van der Linden A
Neurobiol Dis; 2019 Apr; 124():93-107. PubMed ID: 30445024
[TBL] [Abstract][Full Text] [Related]
6. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
[TBL] [Abstract][Full Text] [Related]
7. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
8. Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis.
Mueggler T; Meyer-Luehmann M; Rausch M; Staufenbiel M; Jucker M; Rudin M
Eur J Neurosci; 2004 Aug; 20(3):811-7. PubMed ID: 15255991
[TBL] [Abstract][Full Text] [Related]
9. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
[TBL] [Abstract][Full Text] [Related]
10. Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.
Uryu K; Laurer H; McIntosh T; Praticò D; Martinez D; Leight S; Lee VM; Trojanowski JQ
J Neurosci; 2002 Jan; 22(2):446-54. PubMed ID: 11784789
[TBL] [Abstract][Full Text] [Related]
11. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.
Herzig MC; Winkler DT; Burgermeister P; Pfeifer M; Kohler E; Schmidt SD; Danner S; Abramowski D; Stürchler-Pierrat C; Bürki K; van Duinen SG; Maat-Schieman ML; Staufenbiel M; Mathews PM; Jucker M
Nat Neurosci; 2004 Sep; 7(9):954-60. PubMed ID: 15311281
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
[TBL] [Abstract][Full Text] [Related]
13. Resting state FMRI reveals diminished functional connectivity in a mouse model of amyloidosis.
Shah D; Jonckers E; Praet J; Vanhoutte G; Delgado Y Palacios R; Bigot C; D'Souza DV; Verhoye M; Van der Linden A
PLoS One; 2013; 8(12):e84241. PubMed ID: 24358348
[TBL] [Abstract][Full Text] [Related]
14. Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo.
Kärkkäinen E; Lahtinen HM; Närväinen J; Gröhn O; Tanila H
J Alzheimers Dis; 2015; 46(4):929-46. PubMed ID: 26402627
[TBL] [Abstract][Full Text] [Related]
15. RAGE does not affect amyloid pathology in transgenic ArcAbeta mice.
Vodopivec I; Galichet A; Knobloch M; Bierhaus A; Heizmann CW; Nitsch RM
Neurodegener Dis; 2009; 6(5-6):270-80. PubMed ID: 20145420
[TBL] [Abstract][Full Text] [Related]
16. Diffusion kurtosis imaging to detect amyloidosis in an APP/PS1 mouse model for Alzheimer's disease.
Vanhoutte G; Pereson S; Delgado Y Palacios R; Guns PJ; Asselbergh B; Veraart J; Sijbers J; Verhoye M; Van Broeckhoven C; Van der Linden A
Magn Reson Med; 2013 Apr; 69(4):1115-21. PubMed ID: 23494926
[TBL] [Abstract][Full Text] [Related]
17. Early alterations in functional connectivity and white matter structure in a transgenic mouse model of cerebral amyloidosis.
Grandjean J; Schroeter A; He P; Tanadini M; Keist R; Krstic D; Konietzko U; Klohs J; Nitsch RM; Rudin M
J Neurosci; 2014 Oct; 34(41):13780-9. PubMed ID: 25297104
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
19. Early pathologic amyloid induces hypersynchrony of BOLD resting-state networks in transgenic mice and provides an early therapeutic window before amyloid plaque deposition.
Shah D; Praet J; Latif Hernandez A; Höfling C; Anckaerts C; Bard F; Morawski M; Detrez JR; Prinsen E; Villa A; De Vos WH; Maggi A; D'Hooge R; Balschun D; Rossner S; Verhoye M; Van der Linden A
Alzheimers Dement; 2016 Sep; 12(9):964-976. PubMed ID: 27107518
[TBL] [Abstract][Full Text] [Related]
20. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
